SlideShare une entreprise Scribd logo
1  sur  54
HUMAN PAPILLOMA VIRUS Ahmed Ibrahim
HPV-THE VIRUS HPV-THE INFECTIOUS DISEASE HPV-THE CARCINOGEN HPV/CANCER-THE CURE
HPV-THE INFECTIOUS DISEASE
VIRUSES ds DNA Genome ss DNA Genome ds RNA Genome (+)ss DNA Genome (-)ss DNA Genome RT DNA Genome RT RNA Genome Adenoviridae Papovaviridae Herpesviridae Poxviridae Papilloma Viruses Human Papilloma Viruses 100 serotypes (HPV-16 and HPV 18 highly oncogenic)
[object Object],[object Object],[object Object],Discovery and History of HPV
[object Object],[object Object],[object Object],[object Object],Modes of Transmission
Symptoms of HPV ,[object Object],[object Object],[object Object],[object Object],Pap Test Hybrid Capture II HPV
Clinical Manifestation of HPV ,[object Object],[object Object],[object Object],[object Object],[object Object]
SUPERFICIAL (Flat) WARTS
PLANTAR WARTS
GENITAL CONDYLOMAS
INTERNAL WARTS Also includes Laryngeal warts  (not shown here)
COLORECTAL CONDYLOMAS
 
 
 
 
 
 
 
15% (Koutsky, 1997) Ages 15-49 75% (Koutsky, 1997) Reproductive Age 20 million annually (Cates, 1999) Morbidity Rate 5.5 million  (Cates, 1999) Currently Infected
 
HPV-THE VIRUS
[object Object],[object Object],[object Object],[object Object],[object Object]
 
TREATMENT: Low Grade Lesions ,[object Object],[object Object],[object Object],[object Object]
TREATMENT: High Grade Lesions ,[object Object],[object Object],[object Object],[object Object]
TREATMENT: Genital Warts ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
HP Genomic Replication  Link between gene expression and cellular differentiation Vegetative Replication Plasmid Replication
E2 binds to the early promoter and decreases expression of E6/E7; loss of E2 is thus the first stage in transformation.  E6 binds to p53 via a cellular protein ("p100") and targets it for degradation via the ubiquitin pathway.  E7 binds pRB and prevents phosphorylation. This would normally result in apoptosis BUT:  Both E6 and E7 interact with a number of cellular proteins which influence the outcome of infection:  TRANSFORMATION IN HPV
 
Transcription in HPV
HPV: Structural Proteins Minor capsid protein: possible DNA packaging protein.  L2 Major capsid protein: can form virus-like particles.  L1 Function Gene
HPV: Regulatory Proteins binds to pRB/p107.  E7 Binding p53 protein.  E6 Obstruction of growth suppression mechanisms: e.g EGF receptor; activation of mitogenic signalling pathways via transcription factors: c-Jun and c-Fos. Inactivation of p21.  E5 Late Expression: C terminal binds intermediate filament, allowing release of virus-like particles.  E4 Responsible for recognition and binding of origin of replication.  E2 DNA-dependent ATPase, ATP dependent helices: allow unwinding of the viral genome and act as an elongation factor for DNA replication.  E1 Function Gene
L1 protein in COPV
L2 Major Protein
Visualization of E1 protein bound to HPV-11 origin-containing DNA
E2 Protein E2 binds DNA as a dimer and is sequence specific. The overall secondary structure of the dimer consists of an eight-stranded beta-barrel (magenta) and two pairs of alpha-helices (purple).  Also it is a trans-acting transcriptional activator. The protein is capable of activating a conditional enhancer in the viral long control region, or lcr.
E4 Protein Ability to aggregate into cytoplasm and nuclear inclusion granules. Inclusions are most noticeable in cutaneous lesions. E4 expression coincides with the onset of vegetative viral DNA replication and occurs immediately after cells have left the basal layer (higher layers for mucosal types). Involvement in virus maturation or vegetative viral DNA replication possibly by sequestering inhibitory factors  E4 may interfere with normal differentiation in order to create the conditions required for high level virus synthesis. In the upper layers, E4 and L1 are expressed from the same bicistronic message An important role in productive infection seems likely.
HPV-THE CARCINOGEN
93% of all cervical neoplasia cases test are positive for HPV making it the leading the third leading killer among women X-rays HPV-6, 11 Malignant transformation of respiratory papillomas ??? HPV-16, 18, 31, 33 Lower genital tract cancers U.V., genetic? HPV-5, 8 Skin carcinomas Co-factors: Predominant types: Cancer:
SENSOR of DNA DAMAGE Figure 1 Levine (1997) Cell 88:325 p53 increased levels phosphorylation conformational change oligomerization Transcriptional Activation Cell Cycle Arrest p21 mdm2 Repair GADD45 Apoptosis BAX p53
E6-binding protein
Association with p53: E6 protein requires a cellular protein of 100 kDa, termed E6-associated protein (E6-AP).  E6-dependent degradation of p53 occurs through the cellular ubiquitin proteolysis pathway.  Localized to the nuclear matrix and non-nuclear membrane fraction
1  80  150  276  393 P53 Domain Structure Acidic helical Hydrophobic Proline-Rich Conserved Basic Helical Region of high mutation  Trans-activation 15  22, 23 Sequence-specific DNA Binding Oligomerization Nuclear Localization MDM-2 Domains and Interacting Proteins E1B E6
 
 
E7 promotes degradation of Rb family proteins rather than simply inhibiting their function by complex formation.  The relative carcinogenic potency of the various human papillomavirus types is partially explained by the relative avidity of their respective E7 proteins for Rb,  e.g. , the more tightly a given viral E7 binds Rb, the greater the oncogenic potential of the virus  The E7 protein contains two zinc binding motifs which mediate dimerisation of the protein. Mutation in one of the two Zn binding motifs destroys transforming activity, although this mutant is able to associate with Rb protein.  Zinc binding phosphoproteins which are localised in the nucleus.
 
HPV/Cancer-THE CURE
L1 Major Protein: A potential Vaccine (Koutsky LA, 2002) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
E2 : Another potential treatment (Webster et al 2000)   E2 suppresses expression of E6 and E7 which are both involved in transformation and degradation of tumor suppressor proteins. E2 studies show that IL-2 targeting E2 proteins help accelerate the rate of infection since E6 and E7 go unchecked Overexpression of E2 might suppress HPV infectious cycle
TA-HPV, in which HPV 16 and 18 viral E6 and E7 genes are encoded in a vaccinia virus which on scarification of the site infects and produces the viral proteins. This leads to the generation of HPV specific cytotoxic T cells which can help to eliminate the HPV associated cancer.

Contenu connexe

Tendances

01.04 laboratory diagnosis and monitoring of hiv infection
01.04 laboratory diagnosis and monitoring of hiv infection01.04 laboratory diagnosis and monitoring of hiv infection
01.04 laboratory diagnosis and monitoring of hiv infection
David Ngogoyo
 
HIV/AIDS Presentation - Mobius Disease Project 2012
HIV/AIDS Presentation - Mobius Disease Project 2012HIV/AIDS Presentation - Mobius Disease Project 2012
HIV/AIDS Presentation - Mobius Disease Project 2012
mobiusdiseaseproject
 
Papillomaviruses
PapillomavirusesPapillomaviruses
Papillomaviruses
raj kumar
 
Human Papillomavirus
Human PapillomavirusHuman Papillomavirus
Human Papillomavirus
herffish
 

Tendances (20)

Human papilloma virus
Human papilloma virusHuman papilloma virus
Human papilloma virus
 
01.04 laboratory diagnosis and monitoring of hiv infection
01.04 laboratory diagnosis and monitoring of hiv infection01.04 laboratory diagnosis and monitoring of hiv infection
01.04 laboratory diagnosis and monitoring of hiv infection
 
Human papillomavirus
Human papillomavirusHuman papillomavirus
Human papillomavirus
 
HIV/AIDS Presentation - Mobius Disease Project 2012
HIV/AIDS Presentation - Mobius Disease Project 2012HIV/AIDS Presentation - Mobius Disease Project 2012
HIV/AIDS Presentation - Mobius Disease Project 2012
 
Multipex for papillomavirus
Multipex for papillomavirusMultipex for papillomavirus
Multipex for papillomavirus
 
HPV virus.pptx
HPV virus.pptxHPV virus.pptx
HPV virus.pptx
 
Papillomaviruses
PapillomavirusesPapillomaviruses
Papillomaviruses
 
Human Papillomavirus
Human PapillomavirusHuman Papillomavirus
Human Papillomavirus
 
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
 
human papilloma virus - virology
human papilloma virus - virology human papilloma virus - virology
human papilloma virus - virology
 
Oncogenic viruses
Oncogenic virusesOncogenic viruses
Oncogenic viruses
 
H P V
H P VH P V
H P V
 
Virus Del Papiloma Humano
Virus Del Papiloma Humano Virus Del Papiloma Humano
Virus Del Papiloma Humano
 
Human papillomavirus (hpv)
Human papillomavirus (hpv)Human papillomavirus (hpv)
Human papillomavirus (hpv)
 
Microbiology of HIV
Microbiology of HIVMicrobiology of HIV
Microbiology of HIV
 
Cancer vaccines
Cancer vaccinesCancer vaccines
Cancer vaccines
 
Vph
VphVph
Vph
 
Hpv
HpvHpv
Hpv
 
HPV and Cervical Cancer
HPV and Cervical CancerHPV and Cervical Cancer
HPV and Cervical Cancer
 
Seminar-Oncolytic viruses
Seminar-Oncolytic virusesSeminar-Oncolytic viruses
Seminar-Oncolytic viruses
 

En vedette

Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and Vaccines
Abhijit Chaudhury
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
drsubir
 
Hpv - Human Papilloma Virus
Hpv - Human Papilloma VirusHpv - Human Papilloma Virus
Hpv - Human Papilloma Virus
Zanoula
 
Genital Warts.PROF:AKMAL JAMAL
Genital Warts.PROF:AKMAL JAMALGenital Warts.PROF:AKMAL JAMAL
Genital Warts.PROF:AKMAL JAMAL
akmal jamal
 
Cervical cancer hpv
Cervical cancer hpvCervical cancer hpv
Cervical cancer hpv
Gudang Muslim
 
Atypical Facial Pain
Atypical Facial PainAtypical Facial Pain
Atypical Facial Pain
nationwin
 
Rev4.hpv dna testing for s2011
Rev4.hpv dna testing for s2011Rev4.hpv dna testing for s2011
Rev4.hpv dna testing for s2011
Tariq Mohammed
 

En vedette (20)

Human Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and VaccinesHuman Papilloma Virus : Cervical Cancer and Vaccines
Human Papilloma Virus : Cervical Cancer and Vaccines
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
 
Hpv - Human Papilloma Virus
Hpv - Human Papilloma VirusHpv - Human Papilloma Virus
Hpv - Human Papilloma Virus
 
Atypical facial pain
Atypical facial painAtypical facial pain
Atypical facial pain
 
polyoma virus
polyoma viruspolyoma virus
polyoma virus
 
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
 
Anatomical changes alzheimers transgenics
Anatomical changes alzheimers transgenicsAnatomical changes alzheimers transgenics
Anatomical changes alzheimers transgenics
 
1 dr mario sideri
1  dr mario sideri 1  dr mario sideri
1 dr mario sideri
 
Anogeneital warts
Anogeneital wartsAnogeneital warts
Anogeneital warts
 
Genital Warts.PROF:AKMAL JAMAL
Genital Warts.PROF:AKMAL JAMALGenital Warts.PROF:AKMAL JAMAL
Genital Warts.PROF:AKMAL JAMAL
 
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
 
Cervical cancer hpv
Cervical cancer hpvCervical cancer hpv
Cervical cancer hpv
 
Atypical Facial Pain
Atypical Facial PainAtypical Facial Pain
Atypical Facial Pain
 
Rev4.hpv dna testing for s2011
Rev4.hpv dna testing for s2011Rev4.hpv dna testing for s2011
Rev4.hpv dna testing for s2011
 
Chapter+5,+25,+37 (microbiology) 8th edition
Chapter+5,+25,+37 (microbiology) 8th editionChapter+5,+25,+37 (microbiology) 8th edition
Chapter+5,+25,+37 (microbiology) 8th edition
 
Uses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical ScreeningUses of HPV Testing in Triage of cervical Screening
Uses of HPV Testing in Triage of cervical Screening
 
Facial pain
Facial painFacial pain
Facial pain
 
Orofacial pain 2
Orofacial pain 2Orofacial pain 2
Orofacial pain 2
 
Drug induced gingival enlargement.
Drug induced gingival enlargement.Drug induced gingival enlargement.
Drug induced gingival enlargement.
 

Similaire à Human Papiiloma Virus

Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...
Eliana Cordero
 
Epstein barr virus [autosaved]
Epstein barr virus [autosaved]Epstein barr virus [autosaved]
Epstein barr virus [autosaved]
Karthick Kumar
 

Similaire à Human Papiiloma Virus (20)

Oncogenic dna virus
Oncogenic dna virus Oncogenic dna virus
Oncogenic dna virus
 
sales 1
sales 1sales 1
sales 1
 
HPV - Copy.pptx
HPV - Copy.pptxHPV - Copy.pptx
HPV - Copy.pptx
 
DNA Oncogenic Viruses
DNA Oncogenic VirusesDNA Oncogenic Viruses
DNA Oncogenic Viruses
 
Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...Natural history of human papillomavirus infections, cytologic and histologic ...
Natural history of human papillomavirus infections, cytologic and histologic ...
 
Cancer and virsues
Cancer and virsuesCancer and virsues
Cancer and virsues
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
Molecular localization of epstein barr virus and rb tumor suppressor gene exp...
 
HPV vaccine (UID198612)
HPV vaccine (UID198612)HPV vaccine (UID198612)
HPV vaccine (UID198612)
 
HPV and Cancer
HPV and CancerHPV and Cancer
HPV and Cancer
 
Epstein barr virus [autosaved]
Epstein barr virus [autosaved]Epstein barr virus [autosaved]
Epstein barr virus [autosaved]
 
Molecular basis of head and neck cancer
Molecular basis of head and neck cancerMolecular basis of head and neck cancer
Molecular basis of head and neck cancer
 
oncogenic viruses ppt.
oncogenic viruses ppt.oncogenic viruses ppt.
oncogenic viruses ppt.
 
Oncogenesis is due to uncontrolled cell growth
Oncogenesis is due to uncontrolled cell growthOncogenesis is due to uncontrolled cell growth
Oncogenesis is due to uncontrolled cell growth
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Screening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-DateScreening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-Date
 
Screening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-DateScreening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-Date
 
Screening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-DateScreening Tests for Cervical Cancer Up-To-Date
Screening Tests for Cervical Cancer Up-To-Date
 
MCC 2011 - Slide 4
MCC 2011 - Slide 4MCC 2011 - Slide 4
MCC 2011 - Slide 4
 
STD Prevalence in World, USA and Iran, and Neisseria gonorrhoeae
STD Prevalence in World, USA and Iran, and Neisseria gonorrhoeaeSTD Prevalence in World, USA and Iran, and Neisseria gonorrhoeae
STD Prevalence in World, USA and Iran, and Neisseria gonorrhoeae
 

Plus de ahmedicine (7)

Public Health Situation in Gaza 2009
Public Health Situation in Gaza 2009Public Health Situation in Gaza 2009
Public Health Situation in Gaza 2009
 
Clinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIVClinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIV
 
Autism Study Proposal
Autism Study ProposalAutism Study Proposal
Autism Study Proposal
 
How to Start Undergraduate Research
How to Start  Undergraduate ResearchHow to Start  Undergraduate Research
How to Start Undergraduate Research
 
Hepatitis C in Egypt
Hepatitis C in EgyptHepatitis C in Egypt
Hepatitis C in Egypt
 
ATP-Synthase Presentation
ATP-Synthase PresentationATP-Synthase Presentation
ATP-Synthase Presentation
 
Syringe Purchase Program in Yolo County
Syringe Purchase Program in Yolo CountySyringe Purchase Program in Yolo County
Syringe Purchase Program in Yolo County
 

Human Papiiloma Virus

  • 1. HUMAN PAPILLOMA VIRUS Ahmed Ibrahim
  • 2. HPV-THE VIRUS HPV-THE INFECTIOUS DISEASE HPV-THE CARCINOGEN HPV/CANCER-THE CURE
  • 4. VIRUSES ds DNA Genome ss DNA Genome ds RNA Genome (+)ss DNA Genome (-)ss DNA Genome RT DNA Genome RT RNA Genome Adenoviridae Papovaviridae Herpesviridae Poxviridae Papilloma Viruses Human Papilloma Viruses 100 serotypes (HPV-16 and HPV 18 highly oncogenic)
  • 5.
  • 6.
  • 7.
  • 8.
  • 12. INTERNAL WARTS Also includes Laryngeal warts (not shown here)
  • 14.  
  • 15.  
  • 16.  
  • 17.  
  • 18.  
  • 19.  
  • 20.  
  • 21. 15% (Koutsky, 1997) Ages 15-49 75% (Koutsky, 1997) Reproductive Age 20 million annually (Cates, 1999) Morbidity Rate 5.5 million (Cates, 1999) Currently Infected
  • 22.  
  • 24.
  • 25.  
  • 26.
  • 27.
  • 28.
  • 29.
  • 30. HP Genomic Replication Link between gene expression and cellular differentiation Vegetative Replication Plasmid Replication
  • 31. E2 binds to the early promoter and decreases expression of E6/E7; loss of E2 is thus the first stage in transformation. E6 binds to p53 via a cellular protein ("p100") and targets it for degradation via the ubiquitin pathway. E7 binds pRB and prevents phosphorylation. This would normally result in apoptosis BUT: Both E6 and E7 interact with a number of cellular proteins which influence the outcome of infection: TRANSFORMATION IN HPV
  • 32.  
  • 34. HPV: Structural Proteins Minor capsid protein: possible DNA packaging protein. L2 Major capsid protein: can form virus-like particles. L1 Function Gene
  • 35. HPV: Regulatory Proteins binds to pRB/p107. E7 Binding p53 protein. E6 Obstruction of growth suppression mechanisms: e.g EGF receptor; activation of mitogenic signalling pathways via transcription factors: c-Jun and c-Fos. Inactivation of p21. E5 Late Expression: C terminal binds intermediate filament, allowing release of virus-like particles. E4 Responsible for recognition and binding of origin of replication. E2 DNA-dependent ATPase, ATP dependent helices: allow unwinding of the viral genome and act as an elongation factor for DNA replication. E1 Function Gene
  • 38. Visualization of E1 protein bound to HPV-11 origin-containing DNA
  • 39. E2 Protein E2 binds DNA as a dimer and is sequence specific. The overall secondary structure of the dimer consists of an eight-stranded beta-barrel (magenta) and two pairs of alpha-helices (purple). Also it is a trans-acting transcriptional activator. The protein is capable of activating a conditional enhancer in the viral long control region, or lcr.
  • 40. E4 Protein Ability to aggregate into cytoplasm and nuclear inclusion granules. Inclusions are most noticeable in cutaneous lesions. E4 expression coincides with the onset of vegetative viral DNA replication and occurs immediately after cells have left the basal layer (higher layers for mucosal types). Involvement in virus maturation or vegetative viral DNA replication possibly by sequestering inhibitory factors E4 may interfere with normal differentiation in order to create the conditions required for high level virus synthesis. In the upper layers, E4 and L1 are expressed from the same bicistronic message An important role in productive infection seems likely.
  • 42. 93% of all cervical neoplasia cases test are positive for HPV making it the leading the third leading killer among women X-rays HPV-6, 11 Malignant transformation of respiratory papillomas ??? HPV-16, 18, 31, 33 Lower genital tract cancers U.V., genetic? HPV-5, 8 Skin carcinomas Co-factors: Predominant types: Cancer:
  • 43. SENSOR of DNA DAMAGE Figure 1 Levine (1997) Cell 88:325 p53 increased levels phosphorylation conformational change oligomerization Transcriptional Activation Cell Cycle Arrest p21 mdm2 Repair GADD45 Apoptosis BAX p53
  • 45. Association with p53: E6 protein requires a cellular protein of 100 kDa, termed E6-associated protein (E6-AP). E6-dependent degradation of p53 occurs through the cellular ubiquitin proteolysis pathway. Localized to the nuclear matrix and non-nuclear membrane fraction
  • 46. 1 80 150 276 393 P53 Domain Structure Acidic helical Hydrophobic Proline-Rich Conserved Basic Helical Region of high mutation Trans-activation 15 22, 23 Sequence-specific DNA Binding Oligomerization Nuclear Localization MDM-2 Domains and Interacting Proteins E1B E6
  • 47.  
  • 48.  
  • 49. E7 promotes degradation of Rb family proteins rather than simply inhibiting their function by complex formation. The relative carcinogenic potency of the various human papillomavirus types is partially explained by the relative avidity of their respective E7 proteins for Rb, e.g. , the more tightly a given viral E7 binds Rb, the greater the oncogenic potential of the virus The E7 protein contains two zinc binding motifs which mediate dimerisation of the protein. Mutation in one of the two Zn binding motifs destroys transforming activity, although this mutant is able to associate with Rb protein. Zinc binding phosphoproteins which are localised in the nucleus.
  • 50.  
  • 52.
  • 53. E2 : Another potential treatment (Webster et al 2000) E2 suppresses expression of E6 and E7 which are both involved in transformation and degradation of tumor suppressor proteins. E2 studies show that IL-2 targeting E2 proteins help accelerate the rate of infection since E6 and E7 go unchecked Overexpression of E2 might suppress HPV infectious cycle
  • 54. TA-HPV, in which HPV 16 and 18 viral E6 and E7 genes are encoded in a vaccinia virus which on scarification of the site infects and produces the viral proteins. This leads to the generation of HPV specific cytotoxic T cells which can help to eliminate the HPV associated cancer.